Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at Piper Sandler Healthcare Conference (Virtual) Pre-recorded Transcript

Nov 22, 2021 / 03:00PM GMT
Release Date Price: $4.31 (-4.01%)
James Yoo
Piper Sandler - Managing Director and Healthcare Desk Strategist

Hello and welcome to the 33rd Annual Piper Sandler Healthcare Conference. My name is James Yoo. I'm the healthcare desk strategist at Piper and a managing director at the firm.

This year we are recording fireside chats as part of the virtual event and of course, we all hope to be back in person soon.

Today, we are pleased that members of Fluidigm management have joined us today -- join us to discuss their industry-leading microfluidics and mass cytometry business.

Joining us today are CEO Chris Linthwaite and Vikram Jog, CFO. Welcome.

Chris Linthwaite
Fluidigm Corporation - President and CEO

Thank you, James. I just want to thank the team at Piper for organizing this conference and I know we all wanted to be in person, but this is not a bad fallback position.

I look forward to an opportunity to talk about the business and be optimistic and look forward to 2022 and our ability to meet in person again.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot